The use of terbinafine in the treatment of onychomycosis in adults and special populations: a review of the evidence

Journal of Drugs in Dermatology, May-June, 2005 by Aditya K. Gupta, Jennifer E. Ryder, Lindsay E. Lynch, Amir Tavakkol

41. Jansen R, et al. Cost effectiveness of continuous terbinafine compared with intermittent itraconazole in the treatment of dermatophyte toenail onychomycosis: an analysis of based on results from the L.I.ON. study. Lamisil versus Itraconazole in Onychomycosis. Pharmacoeconomics. 2001;19:401-410.

Aditya K. Gupta MD PhD FRCP(C), (a,b) Jennifer E. Ryder HBSc, (b) Lindsay E. Lynch HBSc (b) Amir Tavakkol PhD Dip Bact (c)

a. Division of Dermatology, Department of Medicine, Sunnybrook and Women's College Health Sciences Center (Sunnybrook site) and the University of Toronto, Toronto, Canada

b. Mediprobe Research, Inc., London, Ontario, Canada

c. US Clinical Development and Medical Affairs, Novartis Pharmaceuticals Corporation, East Hanover, NJ

Address for Correspondence

Dr. Aditya K. Gupta

645 Windermere Road

London, Ontario N5X 2P1, Canada

Phone: 519 657 4222

Fax: 519 657 4233

e-mail: agupta@execulink.com

COPYRIGHT 2005 Journal of Drugs in Dermatology, Inc.
COPYRIGHT 2008 Gale, Cengage Learning

 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
Click Here
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement
Click Here

Content provided in partnership with Thompson Gale